Hostname: page-component-cb9f654ff-5kfdg Total loading time: 0 Render date: 2025-08-21T08:11:18.522Z Has data issue: false hasContentIssue false
  • English
  • Français

Ketamine-assisted meaning-centered psychotherapy for a patient with severe suicidal behavior

Published online by Cambridge University Press:  04 October 2022

Fernando Espí Forcén Open the ORCID record for Fernando Espí Forcén [Opens in a new window] ,
Laura Marengo  and
Maya Behn Open the ORCID record for Maya Behn [Opens in a new window]
Fernando Espí Forcén*
Affiliation:
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Laura Marengo
Affiliation:
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Maya Behn
Affiliation:
Harvard Medical School, Boston, MA, USA
*
Author for correspondence: Fernando Espí Forcén, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Email: fespiforcen@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

There is a current debate in society as to whether depression can be a terminal illness. Meaning-centered psychotherapy (MCP) and psychedelic medicines have both been shown to treat existential distress in palliative care settings. We are reporting the case of a patient for whom MCP combined with ketamine was an effective treatment for his recurrent and severe depressive disorder with suicidal ideation. His complex assessment and management of suicide (CAMS) scores improved significantly with this treatment modality. Ketamine is generally well tolerated and can enhance treatment outcomes in patients undergoing MCP.

Keywords

KetamineMeaning centered psychotherapyComplex assessment and management of suicidePsychedelic psychotherapyDepression

Information

Type
Case Report
Information
Palliative & Supportive Care , Volume 21 , Issue 2 , April 2023 , pp. 362 - 364
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Aleksandrova, LR, Phillips, AG and Wang, YT (2017) Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. Journal of Psychiatry & Neuroscience: JPN 42(4), 222–229. doi:10.1503/jpn.160175CrossRefGoogle ScholarPubMed
Breitbart, W (ed) (2017) Meaning-Centered Psychotherapy in the Cancer Setting: Finding Meaning and Hope in the Face of Suffering. Oxford, UK: Oxford University Press.CrossRefGoogle Scholar
Breitbart, W, Pessin, H, Rosenfeld, B, et al. (2018) Individual meaning-centered psychotherapy for the treatment of psychological and existential distress: A randomized controlled trial in patients with advanced cancer. Cancer 124(15), 3231–3239. doi:10.1002/cncr.31539CrossRefGoogle ScholarPubMed
Breitbart, W and Poppito, SR (2014) Individual Meaning-Centered Psychotherapy for Patients with Advanced Cancer: A Treatment Manual. Oxford, UK: Oxford University Press.CrossRefGoogle Scholar
Breitbart, W, Poppito, S, Rosenfeld, B, et al. (2012) Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(12), 1304–1309. doi:10.1200/JCO.2011.36.2517CrossRefGoogle ScholarPubMed
Dierickx, S, Deliens, L, Cohen, J, et al. (2017) Euthanasia for people with psychiatric disorders or dementia in Belgium: Analysis of officially reported cases. BMC Psychiatry 17(1), 203. doi:10.1186/s12888-017-1369-0CrossRefGoogle ScholarPubMed
Dore, J, Turnipseed, B, Dwyer, S, et al. (2019) Ketamine Assisted Psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy. Journal of Psychoactive Drugs 51(2), 189–198. doi:10.1080/02791072.2019.1587556CrossRefGoogle ScholarPubMed
Frankl, VE (2014) Man’s Search for Meaning. Boston, MA: Beacon Press.Google Scholar
Griffiths, RR, Johnson, MW, Carducci, MA, et al. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England) 30(12), 1181–1197. doi:10.1177/0269881116675513CrossRefGoogle Scholar
Grob, CS, Danforth, AL, Chopra, GS, et al. (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry 68(1), 71–78. doi:10.1001/archgenpsychiatry.2010.116CrossRefGoogle ScholarPubMed
Jelen, LA, Young, AH and Stone, JM (2021) Ketamine: A tale of two enantiomers. Journal of Psychopharmacology (Oxford, England) 35(2), 109–123. doi:10.1177/0269881120959644CrossRefGoogle ScholarPubMed
Jobes, DA, Comtois, KA, Brenner, LA, et al. (2016) Trials of the Collaborative Assessment and Management of Suicidality (CAMS). In The International Handbook of Suicide Prevention. Hoboken, NJ: WIley, 431–449.CrossRefGoogle Scholar
Krupitsky, EM and Grinenko, AY (1997) Ketamine psychedelic therapy (KPT): A review of the results of ten years of research. Journal of Psychoactive Drugs 29(2), 165–183. doi:10.1080/02791072.1997.10400185CrossRefGoogle ScholarPubMed
Trachsel, M, Irwin, SA, Biller-Andorno, N, et al. (2016) Palliative psychiatry for severe persistent mental illness as a new approach to psychiatry? Definition, scope, benefits, and risks. BMC Psychiatry 16, 260. doi:10.1186/s12888-016-0970-yCrossRefGoogle ScholarPubMed
Tyndal, T, Zhang, I and Jobes, DA (2021) The Collaborative Assessment and Management of Suicidality (CAMS) stabilization plan for working with patients with suicide risk. Psychotherapy (Chicago, III) 52(2), 143–149. doi:10.1037/pst0000378Google Scholar